Knockdown of PRNCR1 downregulates the expression of cyclin D2, induces G0/G1 phase arrest of the BC cell cycle, and inhibits BC progression through the miR-377/CCND2/MEK/MAPK axis (Ouyang et al., 2021). Here, CCND2 is linked to breast cancer.